INSMED Inc director Brennan David R sold 25,000 shares at $124 per share on Sep. 9, 2026, under transaction code S. The sale represented about 38.9% of his prior holding and left him with 39,238 shares, allowing investors to assess the director’s remaining ownership exposure.
Key Highlights
- Brennan David R held 39,238 INSMED shares after the transaction.
- The sale represented about 38.9% of his prior shareholding.
- The transaction was recorded under code S, identifying a sale.
INSMED Inc (NASDAQ: INSM) director Brennan David R sold 25,000 shares at $124 per share on Sep. 9, 2026.
Director Sale Details
Brennan David R’s ownership stood at 39,238 INSMED shares after the transaction. The sale price was $124 per share. The transaction’s size represented about 38.9% of Brennan David R’s prior shareholding. The reported post-transaction ownership figure was 39,238 shares.
Remaining Ownership After Transaction
The 38.9% figure measures the sale against Brennan David R’s prior holding. The sale took place on Sep. 9, 2026.
FAQs
Q: How many INSMED shares did Brennan David R sell?
A: Brennan David R sold 25,000 INSMED shares at $124 per share on Sep. 9, 2026. The transaction used code S.
Q: What does Brennan David R’s INSMED share sale mean for investors?
A: The transaction left Brennan David R with 39,238 INSMED shares. It represented about 38.9% of his prior holding, the reported ownership comparison for the sale.
Q: What was the INSMED director’s remaining stake after the sale?
A: After selling 25,000 shares, Brennan David R held 39,238 INSMED shares. The sale was executed at $124 per share on Sep. 9, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.